Hi {{ session.user.profile.firstName }}

Health IT

  • In this webinar, learn about the new capabilities in the Informatica PowerCenter 10 editions and how they will increase your development agility.

    Through the eyes and daily routine of typical developers and business analysts you will discover how this new release:
    . Enhances the collaboration between IT developers and business analysts
    . Delivers more powerful visualization for data profiling
    . Delivers a new monitoring dashboard to view service health and system usage
    . Increases your productivity with up to 50X faster data lineage rendering
    . Enhances your project reach with new connectors and real time capabilities
    . Includes new capabilities for parsing semi-structured and unstructured data

    Watch this webinar to accelerate your deliver of data integration-based value to your organization.
  • Are you ready to transform healthcare with predictive analytics? Are you ready to turn Data into Insights and Insights into Practice? Predictive Analytics is about making better healthcare decisions. Is your organization Future Ready?
  • Are you ready to improve patient care, reduce risk and optimize resources? Are you ready for Predictive Analytics? Analytics is about making better business decisions. Do you understand what the customers want from you? Is your organization Future Ready?
  • Are you ready to make the most of your clinical technology investments? Dell Clinical application services connect clinical providers with critical patient information whenever and wherever it's needed. Like providing end to end applications and EHR solutions and services. We enhance the provider patient experience by ensuring that the right information is available at a moment's notice. Is your organization Future Ready?
  • Are you ready to engage with your patients? 40% of patients in US struggle with Chronic health conditions. The most improtant treatment protocol requires healthy lifestyle choices. But to take control and make these changes many patients need support. Dell Patient Engagement Solutions can provide that support. Is your organization Future Ready?
  • Richard Mendel MD, a Spinal Neurosurgeon from Tampa, Florida, gives a presentaion on the Basics of Stem Cells. Stem Cell Treatments are becoming more popular, and it benefit all to know the basics of this growing science.
  • Is your healthcare organization taking advantage of Cloud benefits? Cloud can help you simplify IT management and drive down the cost of IT operations. Dell secure healthcare cloud gives you access to industry leading security to reduce of burden of industry regulatory requirements and get the flexibility to adapt to the future. Is your organization Future Ready?
  • In recent days we have heard from CEO’s about the challenges they face when a breach occurs in determining what data has been lost. Was it sensitive customer data? If so, how many customers are impacted? Not knowing this information immediately causes further damage to customer confidence and significantly increases the cost of dealing with the breach itself.

    In this webinar Informatica will introduce a new generation of Data Security Intelligence capabilities which will provide insight into exactly where company and customer sensitive data resides, how it is moving through the organization and what security measures are in place to protect it. We will also look at some of the proactive measures that can be quickly put in place at the database layer to prevent even authorized staff credentials from making unusual data requests, which are often the precursor to a costly breach.

    We hope you can join us for what promises to be an informative and highly topical webinar.
  • Trinity Health is an 86-hospital system that recently completed a large merger with Catholic Health East. With demand for analytics across the enterprise growing faster than ever before, Trinity Health was in urgent need for gaining easy access to high quality, trusted data. One of the most pressing challenges for Trinity Health was to manage the inconsistent data from variety of applications as it was being moved in and out of different data warehouse systems. In order to extend their analytics platform beyond financials to include clinical, operational, and third party data, they needed to deliver connected, safe, and clean data. This meant adding data quality and master data management capabilities to their architecture. In addition to technology, Trinity Health relied on an enterprise-wide, comprehensive data governance and data investigation program to ensure the overall success of the analytics initiative.

    This webinar will cover how the Trinity Health team achieved consensus for this program, collaborated with business and technical colleagues, and advanced data governance as a best practice to support advanced analytic initiatives.

    During this webinar, you'll learn how to:

    • Implement the best health information management technology
    • Boost your agility to gain insight from healthcare data for better patient outcomes
    • Facilitate patient data centricity for reduced costs with clean, safe data
  • Th​is webinar will provide an overview on the topic of analyzing various fatty species in foods and methods to determine various classes from total fat to various lipid fractions and the wide variety of analyses available for fat determination. Topics discussed will include the analyses of fatty acid methyl esters (FAMES) in foods and the use of comprehensive two-dimensional gas chromatography (GC x GC) for the enhanced separation of highly complex mixtures. Advances in GC column stationary phases and new phases based on ionic liquid technology for the analyses of saturated and polyunsaturated FAMES will be discussed aswell as the use of GC×GC in the field of food lipid analysis. The considerable advantages of the two-dimensional approach (both with and without MS detection), in experiments related to a series of lipid volatiles (fatty acids, sterols, oxidation products, fatty alcohols, etc) will be illustrated.

    In this webinar, we will:

    > Overview the wide variety of methods available for the analysis of fat in foods.

    > Examine traditional and new classes of GC Stationary Phases for the evaluation of various FAME species.

    > Discuss the power of two-dimensional gas chromatography (GCxGC) for separating highly complex mixtures and how it can be combined with mass spectrometry for analyzing volatile and semi-volatile analytes
  • Digital – a word which is ubiquitous within our industry now and no longer the exclusive domain of IT or marketing. It should not be seen as simply an enabler; intelligent and progressive digitisation is now a fundamental business need in all areas of pharma and healthcare.

    We present an exclusive webinar with global data centre and interconnectivity specialist Equinix, joined by digital and technology experts FFW and moderated by our own Paul Tunnah. This debate will provide practical insight and delve deep into the challenges at hand in managing the digitisation of our industry.

    Topics covered will include:
    •Why being digital is no longer an IT function but rather a business need – analysis and insight into the current market and the coming 3 to 5 years
    •Managing data – how pharma needs to change its IT foundations to remain commercially optimised in a changing healthcare environment, including the move from pill to patient
    •How industry can prepare – why connected is not enough – definition and benefits of interconnectivity, with learnings from the financial sector
  • Pharmaceutical companies play an ever increasing role in the treatment and prevention of illnesses. Many leading Pharma companies depend on third-party organizations, like the Almac Group, to help conduct testing, research and trials to improve the overall drug development process.

    Almac is a global leader in contract pharmaceutical development and manufacturing services, and recently deployed scriptless test automation to improve its core business application testing in support of its overall business agility goals.

    This session will focus on how Almac and TurnKey Solutions partnered to successfully shorten test cycles and improve test outcomes - supporting more rapid deployment cycles for core applications and end-to-end business critical processes.

    Shauna Quinn, Software Test Manager for Almac, will share recent results and 4 lessons learned in Almac’s implementation of scriptless test automation, including:

    How to build a better alternative to manual testing methods, which for Almac, previously took 20 people and 12 weeks to run
    How to streamline operations and shrink testing cycles from multiple weeks to only 3-4 days
    How automation helped to quickly and easily validate core business systems using a comprehensive regression suite
    How this intuitive software provided a solid testing strategy moving forward
  • Continuing the successful series of webinars with the Visitor and Migrant NHS Cost Recovery Team, join us for another chance to talk to colleagues from the Department of Health, Monitor and NHS England about the financial incentives, billing mechanisms and NHS debtor’s scheme

    The NHS Cost Recovery Team is leading work to improve systems for identifying and charging overseas visitors and migrants who use the NHS. This programme of work, though led by the Department, is being co produced with delivery partners in NHS England and the wider NHS, the Health and Social Care Information Centre (HSCIC), the Home Office and the Department for Work and Pensions (DWP). We aim to support and reinforce the principle of fairness by ensuring that everyone who can should contribute to the cost of the NHS.
  • Get an overview of the new dashboard and functionality in the latest PCoIP Management Console Enterprise Edition (2.0) to make managing your Tera2 PCoIP Zero Clients even easier. We’ll provide you with a live demo of the new capabilities, so you’ll know how to:

    • Install and activate the software
    • Update Tera2 PCoIP Zero Clients with firmware 5.0
    • Discover your PCoIP Zero Clients by using DNS SRV records
    or DHCP options
    • Manage your end-points

    Those who attend the webinar will receive a copy of the slide deck and a link to the recording.

    Q&A will follow at the end of the session.

    To share with others via Twitter: #ManageMyZeros
  • What you’ll learn about the AU5800 chemistry analyzer:

    •Typical performance observed (reproducibility, reference ranges)
    •Impact on the laboratory’s turnaround time (TAT) targets
    •Operator feedback on instrument features
    •Instrument uptime metrics

    P.A.C.E. credit will be available for your participation*
  • See an overview of the new dashboard and functionality in the new PCoIP Management Console Enterprise Edition to make managing your Tera2 PCoIP Zero Clients even easier. We’ll provide you with a demo of the new capabilities and tips on how to:

    •Install and activate the software
    •Update Tera2 PCoIP Zero Clients with firmware 5.0
    •Discover your PCoIP Zero Clients
    •Using DNS SRV records
    •Using DHCP options
    •Identify and manage all your end-points

    Q&A will follow at the end of the session.

    Follow us on Twitter: #ManageMyZeros
    Questions? sales@teradici.com
  • Chemical probes are powerful reagents with increasing impacts on biomedical research. However, probes of poor quality or that are used incorrectly generate misleading results. To help address these shortcomings, we are building a community-driven online resource to improve quality and convey current best practice.
    In this presentation, we will highlight some selected examples of promising, high quality chemical probes and probes of lesser value. We will discuss the prevalence of using lesser quality probes and the costs. We will then detail our plans to develop the Chemical Probes Portal, a web-based resource annotated by the chemical biology community that allows users to reference the most appropriate chemical probe (or probes) for a given protein target. The Portal will be an online community of scientists, reviewers, editors.
  • Future-Focused Finance, through its Great Place to Work action area, aims to enable individuals and teams to develop themselves to have rewarding and enjoyable careers in the NHS. Coaching & Mentoring are integral parts of this action area: the work stream aims to develop potential at all levels of the finance function. We have developed a series of six free webinars that seeks to give participants the skills to develop effective Coaching & Mentoring relationships and skills as both coach/coachee and mentor/mentee.

    The third of the 6 webinars is entitled “Active Listening and Powerful Questioning”. The fast-paced environment that today’s NHS finance professionals operate in means that we all expect things to happen now. Because of this, we often don’t take time to listen or question effectively. Strong questioning and listening skills are at the heart of coaching and mentoring and are key to mutual communication and understanding. Active listening is a way of listening and responding to another person that improves mutual understanding. It is listening beyond the words or ‘facts’ and focuses the attention on the speaker. The most effective questions are powerful and thought provoking, they can jump-start creativity, change our perspective, empower us to believe in ourselves, push us to think things through or call us to action.

    Whether you’re new to Coaching & Mentoring, or looking to refresh your existing skills, join Sotiris Kyriacou, Future-Focused Finance, Great Place to Work Workstream Lead for Coaching and Mentoring, Jonathan Bowyer, Executive Coach, HFMA and Claire Merrick, Coaching & Mentoring Services Manager, to find out more.
  • Join Microsoft Chief Strategist James Staten and HOSTING VP of Product Sean Bruton for this eye-opening exploration into – and discussion about – the successful union of Azure with managed services to optimize your cloud (and business) performance.
  • The importance of genetic variations in drug transporters for drug disposition and response has been increasingly recognized in the past decade. The drug transporter organic anion transporting polypeptide 1B1 (OATP1B1) is genetically polymorphic and plays a major role in hepatic uptake of a variety of clinically important drugs. Predicting the pharmacokinetic effect of these genetic variants on the drug disposition is critical for understanding the inter-individual variations to drug efficacy and safety. Corning TransportoCells was introduced to support in vitro assessment of drug interaction with SLC transporter. Specially, the newly developed TransportoCells OATP1B1 SNPs, alongside with OATP1B1 wild type, offer an in vitro tool kit for studying the potential impact of genetic variants on drug PK.

    This webinar will focus on the development and characterization of the newly available TransportoCells OATP1B1 genetic variants, three animal species Oatp family members and other drug transporters of emerging importance in drug development.
  • VM replication technologies like SRM or Zerto aren’t always the best way to replicate and protect all workloads. For example, most databases have native replication that’s more context-sensitive than hypervisor-based block-level replication. Join me, Darrell Hyde, HOSTING CTO, on November 12, 2015 for DR in the Cloud: Finding the Right Tool for the Job – an interactive webinar where I’ll discuss:
    •Common use cases
    •Different approaches to DR
    •Pros and cons of each approach
    Bring your questions for a live Q&A at the end of the webinar! I’ll see you there!
  • Drug target validation is a major obstacle to drug development leading to high rates of late-stage failure because the pivotal study in drug development - the randomised trial – occurs at the end of the development pipeline.

    Genetic studies using the principle of Mendelian randomisation reproduce key elements of a randomised trial ensuring target validation can take place earlier in development.

    A second major obstacle in drug development is the understanding of individual differences in drug efficacy and safety due to naturally occurring variation in gene encoding proteins involved in drug disposition – a key component of stratified medicines research.

    The Illumina Drug Development Array is designed to address issues and enable genomic discoveries to be used in drug development.

    The array combines the genome-wide tag SNP content of the Illumina Human Core BeadChip (240,000 highly-informative genome-wide tag SNPs and over 20,000 high-value markers) with a novel 200,000 custom marker set designed to support studies of drug target validation and treatment response. The array is relevant to full range of human drug targets and medical disorders.

    The webinar will:

    - Introduce the concept of Mendelian randomisation studies for target selection and validation in drug development

    - Discuss the concept of the ‘druggability’ and the ‘druggable genome’

    - Describe development of the content of the Illumina drug development array based on an updated set of genes encoding druggable targets and the proteins involved in in drug absorption, distribution, metabolism and excretion (ADME)


    - Prof. Aroon Hingorani, Chair of Genetic Epidemiology, Institute of Cardiovascular Science, University College London

    - Prof. John Overington, Visiting Professor of Computational Chemical Biology, Institute of Cardiovascular Science, University College London

    - Dr. Anna Gaulton, Senior Data Integration and Development Officer – ChEMBL, European Bioinformatics Institute, Hinxton
  • New stories of massive HIPAA breaches continue to spring up almost daily. Whether caused by oversight or negligence, fines, lawsuits, and the impact on reputation represent very real threats. Join this webinar to learn the value new communications technologies can provide and how to ensure your patient data and your business remain protected and compliant under HIPAA law.
  • Last year we spoke about enterprise perceptions towards advanced persistent threats, or as 451 Research terms them adaptive persistent threats. The acknowledgement that there are threat classes that can not be rebuffed by preventative security controls has led to a refocus on security monitoring for many enterprise heads of information security, but the approach is not without its challenges, including notably complexity and manpower. Join Dan Kennedy, Research Director for Information Security at 451 Research on November 10, 2015 to review portions of two end user studies on enterprise perception towards major security monitoring platforms: SIEM and IDS/IPS. The presentation will draw on results of over two thousand surveys conducted with enterprise information security managers.
  • Do you know how to effectively manage medication processes to meet regulations related to drug diversion? We wrap up the 2015 webinar series by taking a look at medication security guidelines that are highly recommended to prevent drug diversion in your facility. In this webinar, the following topics will be discussed:

    • Best practices for medication security processes to prevent diversion of controlled substances.
    • Consequences of drug diversion including the spread of infectious diseases, deaths, and fines charged by the DEA.
    • Past drug diversion activity at facilities that lacked processes to monitor diversion.